EUSA submits Erwinase BLA

EUSA Pharma Inc. (Langhorne, Pa.) completed submission of a rolling BLA to FDA for Erwinase to treat acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to Escherichia coli-derived a...